Suppr超能文献

散发性醛固酮瘤的免疫组织化学、遗传学及临床特征

Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

作者信息

Monticone Silvia, Castellano Isabella, Versace Karine, Lucatello Barbara, Veglio Franco, Gomez-Sanchez Celso E, Williams Tracy A, Mulatero Paolo

机构信息

Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Torino, Italy.

Division of Pathology, Department of Medical Sciences, University of Torino, Torino, Italy.

出版信息

Mol Cell Endocrinol. 2015 Aug 15;411:146-54. doi: 10.1016/j.mce.2015.04.022. Epub 2015 May 6.

Abstract

Adrenal glands removed for unilateral primary aldosteronism (PA) display marked histological heterogeneity. Recently reported somatic mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D can partially account for these differences. In this study we aimed at combining phenotypic and genotypic characteristics, integrating genetic and immunohistochemistry correlates in sporadic PA. Seventy-one adrenal glands have been included in the study and analyzed for mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D. Histological examination and immunohistochemical staining for CYP11B1 (11β-hydroxylase) and CYP11B2 (aldosterone synthase) were performed on aldosterone-producing adenomas (APAs) and adjacent adrenal cortex. In our cohort, the final histopathological diagnosis was multinodular hyperplasia in 22.5% of the patients and single nodule in 77.5%. Forty-five percent of the removed adrenals displayed extra-APA CYP11B2-positive cell nests (B2-CN). Among adrenal vein sampling parameters the suppression of contralateral adrenal was more frequent and the lateralization index was higher in the subgroup of patients without extra-APA B2-CN compared to the subgroup with extra-APA B2-CN. KCNJ5-mutated APAs were composed mainly of zona fasciculata-like cells with high expression of CYP11B1, while ATP1A1, ATP2B3 and CACNA1D-mutated APAs presented more frequently a zona-glomerulosa-like phenotype with high expression of CYP11B2. We observed a significant inverse correlation between CYP11B2 expression and the size of the nodules and, if CYP11B2 expression was corrected for tumor volume, a significant correlation with plasma aldosterone and aldosterone to renin ratio. Our findings indicate that combination of genotyping and immunohistochemistry improves the final histopathological diagnosis between single nodule and multinodular hyperplasia of the assessed adrenals.

摘要

因单侧原发性醛固酮增多症(PA)而切除的肾上腺显示出明显的组织学异质性。最近报道的KCNJ5、ATP1A1、ATP2B3和CACNA1D体细胞突变可部分解释这些差异。在本研究中,我们旨在结合表型和基因型特征,整合散发性PA中的基因与免疫组化相关性。本研究纳入了71个肾上腺,并分析了KCNJ5、ATP1A1、ATP2B3和CACNA1D的突变情况。对醛固酮瘤(APA)及相邻肾上腺皮质进行了组织学检查以及CYP11B1(11β-羟化酶)和CYP11B2(醛固酮合酶)的免疫组化染色。在我们的队列中,最终组织病理学诊断为多结节增生的患者占22.5%,单结节患者占77.5%。45%的切除肾上腺显示出APA外CYP11B2阳性细胞巢(B2-CN)。在肾上腺静脉采血参数中,与有APA外B2-CN的亚组相比,无APA外B2-CN的患者亚组中对侧肾上腺抑制更常见,且侧化指数更高。KCNJ5突变的APA主要由束状带样细胞组成,CYP11B1表达较高,而ATP1A1、ATP2B3和CACNA1D突变的APA更常呈现球状带样表型,CYP11B2表达较高。我们观察到CYP11B2表达与结节大小之间存在显著负相关,并且如果校正肿瘤体积后的CYP11B2表达与血浆醛固酮和醛固酮与肾素比值存在显著相关性。我们的研究结果表明,基因分型与免疫组化相结合可改善对评估肾上腺的单结节与多结节增生的最终组织病理学诊断。

相似文献

1
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Mol Cell Endocrinol. 2015 Aug 15;411:146-54. doi: 10.1016/j.mce.2015.04.022. Epub 2015 May 6.
2
Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Hypertension. 2015 Nov;66(5):1014-22. doi: 10.1161/HYPERTENSIONAHA.115.05993. Epub 2015 Sep 8.
4
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27.
5
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.
6
Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e282-9. doi: 10.1210/clinem/dgz235.
7
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Endocr Relat Cancer. 2015 Oct;22(5):735-44. doi: 10.1530/ERC-15-0321.
8
Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
Hypertension. 2020 Apr;75(4):1034-1044. doi: 10.1161/HYPERTENSIONAHA.119.14177. Epub 2020 Mar 2.
9
Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel Mutation.
Hypertension. 2017 Jul;70(1):129-136. doi: 10.1161/HYPERTENSIONAHA.117.09057. Epub 2017 Jun 5.
10
Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1182-1192. doi: 10.1210/jc.2016-2986.

引用本文的文献

2
Somatic Mutations Associated with Aldosterone-Producing Adenomas (APAs).
Genes (Basel). 2025 Jun 30;16(7):778. doi: 10.3390/genes16070778.
3
Histopathological spectrum of common aldosterone-driver gene mutations in aldosterone-producing adenomas.
Front Med (Lausanne). 2025 Jun 10;12:1569619. doi: 10.3389/fmed.2025.1569619. eCollection 2025.
4
Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours.
Endocr Connect. 2025 Jun 26;14(6). doi: 10.1530/EC-25-0070. Print 2025 Jun 1.
7
Clinical significance of CYP11B2 immunostaining in unilateral primary aldosteronism.
Endocr Connect. 2024 Jan 12;13(2). doi: 10.1530/EC-23-0344. Print 2024 Feb 1.
8
Primary aldosteronism: molecular medicine meets public health.
Nat Rev Nephrol. 2023 Dec;19(12):788-806. doi: 10.1038/s41581-023-00753-6. Epub 2023 Aug 23.
9
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.
Endocr Rev. 2024 Jan 4;45(1):125-170. doi: 10.1210/endrev/bnad026.
10
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.
Nat Genet. 2023 Jun;55(6):1009-1021. doi: 10.1038/s41588-023-01403-0. Epub 2023 Jun 8.

本文引用的文献

1
Dissecting the molecular pathways of primary aldosteronism.
Pathol Int. 2014 Oct;64(10):482-9. doi: 10.1111/pin.12200. Epub 2014 Oct 2.
2
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.
Mol Cell Endocrinol. 2015 Jan 5;399:311-20. doi: 10.1016/j.mce.2014.09.015. Epub 2014 Sep 18.
3
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy.
J Clin Endocrinol Metab. 2014 Nov;99(11):4158-66. doi: 10.1210/jc.2014-2345. Epub 2014 Aug 13.
4
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27.
5
Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas.
Hypertension. 2014 Aug;64(2):438-44. doi: 10.1161/HYPERTENSIONAHA.113.02944. Epub 2014 May 19.
6
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol.
Lancet Diabetes Endocrinol. 2015 Apr;3(4):296-303. doi: 10.1016/S2213-8587(14)70069-5. Epub 2014 May 13.
7
Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
J Clin Endocrinol Metab. 2014 Jul;99(7):E1341-51. doi: 10.1210/jc.2013-4255. Epub 2014 Apr 23.
8
Development of monoclonal antibodies against human CYP11B1 and CYP11B2.
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):111-7. doi: 10.1016/j.mce.2013.11.022. Epub 2013 Dec 8.
9
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.
10
Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.
J Clin Endocrinol Metab. 2013 Dec;98(12):4826-33. doi: 10.1210/jc.2013-2805. Epub 2013 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验